Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 51-54

  Esselen, Katharine M ^a,b   Rodriguez, Noah ^a   Growdon, Whitfield ^b   Krasner, Carolyn ^b   Horowitz, Neil S ^a,c   Campos, Susana ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Fallopian tube; Intraperitoneal chemotherapy; Ovarian; Peritoneal; Recurrence

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CATHETER INFECTION; CYTOREDUCTIVE SURGERY; DEHYDRATION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; OVARY CARCINOMA; OVERALL SURVIVAL; PERITONEUM CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; UTERINE TUBE CARCINOMA; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84865692923     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.05.026     Document Type: Article

References (9)

1. R. Siegal, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011 CA Cancer J Clin 61 4 2011 212 236
2. S.A. Cannistra Cancer of the ovary N Engl J Med 351 2004 2519 2529
3. D.S. Alberts, P.Y. Liu, E.V. Hannigan, R. O'Toole, S.D. Williams, and J.A. Young Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer N Engl J Med 335 26 1996 1950 1955
4. M. Markman, B.N. Bundy, D.S. Alberts, J.M. Fowler, D.L. Clark-Pearson, and L.F. Carson Phase III trial of standard dose intravenous cisplatin plus paclitaxel versus moderately high dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwest Oncology Group and Eastern Cooperative Oncology Group J Clin Oncol 19 4 2001 1001 1007
5. D.K. Armstrong, B. Bundy, J.L. Wenzel, and R.A. Burger Gynecologic Oncology Group: intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 1 2006 34 43
6. G. Cormio Distant metastases in ovarian carcinoma Int J Gynecol Cancer 13 2003 125 129
7. E.J. Tanner, D.R. Black, O. Zivanovic, S.M. Kehoe, F. Dao, and J.A. Konner Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer Gynecol Oncol 124 2012 59 62
8. D.S. Chi, K. McCaughty, J.P. Diaz, J. Huh, S. Schwabenbauer, and A.J. Hummer Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma Cancer 106 2006 1933 1939
9. R. Salani, A. Santillan, M. Zahurak, R.L. Giuntoli, G.J. Gardner, and D.K. Armstrong Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer Cancer 109 2007 685 691